ORKA FY 2023 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$111,000

Operating Income

-$7M

Net Income

-$5M

EPS (Diluted)

$-4.44

Balance Sheet

Total Assets

$38M

Total Liabilities

$841,000

Stockholders' Equity

$37M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$111,000	-$114,000	+2.6%
Operating Income	-$7M	-$10M	+25.9%
Net Income	-$5M	-$10M	+46.2%